Investor Relations Captor Therapeutics ®

FAQ

- Who is the statutory auditor of the Company?
  - The statutory auditor for Captor Therapeutics is Grant Thornton Polska P.S.A., ul. Abpa Antoniego Baraniaka 88E, 61-131 Poznań. The company is entered on the list of audit firms kept by the National Council of Statutory Auditors under reference number 4055.
- Does the Company meet with investors? How can you find out about planned meetings?
  - Captor Therapeutics meets with investors regularly, both at individually scheduled sessions and at national and international conferences dedicated to the market. Captor Therapeutics communicates with investors through social media, responding to questions asked in every available channel and via the email.
- Where is Captor Therapeutics headquartered?
  - Captor Therapeutics is headquartered at Duńska 11, 54-427 Wrocław.
- How is Captor Therapeutics’ stock traded?
  - Captor Therapeutics is traded on the Warsaw Stock Exchange under the symbol “CAPTORTX”.
- When did Captor Therapeutics go public?
  - Captor Therapeutics priced its initial public offering (IPO) on April 8, 2021 at a price of PLN 172 per share. Captor’s common stock began trading on April 19, 2021.
- When does Captor Therapeutics’ fiscal year end?
  - Our fiscal year end is December 31.